Evidence map›Paper›PMID 41851956›Full record

ArticleFacts, views & vision in ObGyn2026

The past, present and future of uterine fibroids.

Fred Burbank, George A Vilos, Angelos G Vilos

Abstract read
In one paragraph

Article in Facts, views & vision in ObGyn, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fred BurbankSalt Creek International Women's Health Foundation, California, United States of America.
George A VilosDepartment of Obstetrics and Gynecology, Western University, Schulich School of Medicine and Dentistry, Ontario, Canada.ORCID 0000-0002-2007-8791
Angelos G VilosDepartment of Obstetrics and Gynecology, Western University, Schulich School of Medicine and Dentistry, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human evolution -specifically the development of bipedalism- altered the shape of the pelvis so that legs alone provided locomotion across the ground. As a result, the forelimbs were freed from locomotion. Though speculative, hands freed from locomotion may have led to the expansion of hand tool use and brain enlargement. With a pelvis no longer optimised for childbirth and with larger fetal brains, childbirth became more challenging. An "obstetrical dilemma" was created. How could large-headed babies be pushed through a narrowed, convoluted pelvis? More uterine muscle, a "neomyometrium," evolved in the uterus, to increase the force of contractions. Because fibroids develop from myometrial tissue, additional fibroids came along with the neomyometrium. Until recently, the fibroid burden that accompanied bipedalism did not become apparent until the advent of modern contraception. Mendelian randomisation studies have demonstrated causal links between women's reproductive histories and their risk of developing fibroids. Multiparity and infrequent menstruation, universally common until only recently, kept this fibroid risk hidden until socio-demographic changes and hormonal contraception unmasked fibroids that evolved with the neomyometrium. Simple therapeutic approaches that (i) periodically and temporarily emulate the clot formation that occurs within the blood vessels of the uterus following childbirth and that (ii) reduce the number of lifetime menstrual cycles may be able to reduce the current high incidence of fibroids.

Indexed as

Birth ratehormonal contraceptionMendelian randomisationmenstruationmyometriumuterine fibroids

Identifiers

PMID41851956
PMCPMC13000352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.